Treatment-Related Diarrhea in Patients With Cancer

被引:17
|
作者
Shaw, Colleen [1 ]
Taylor, Loryn [2 ]
机构
[1] Florida Canc Specialists, Tampa, FL USA
[2] Tampa Gen Hosp, Tampa, FL 33606 USA
关键词
IRINOTECAN-INDUCED DIARRHEA; DOUBLE-BLIND; CHEMOTHERAPY; RADIOTHERAPY; PROPHYLAXIS; PREVENTION; PROBIOTICS; NEOMYCIN; PLACEBO;
D O I
10.1188/12.CJON.413-417
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diarrhea caused by chemotherapy or radiation in patients with cancer can cause dehydration, electrolyte imbalance, malnutrition, fluid depletion, and hospitalization. In severe cases, uncontrolled diarrhea can lead to therapy dose reductions or even death. Oncology professionals may simply assess for the absence or presence of diarrhea, rather than using a standard assessment tool; they also may lack awareness regarding availability of established assessment and treatment guidelines. However, use of treatment guidelines can lead to optimal prevention and management of treatment-induced diarrhea in patients with cancer. Oncology nurses play a key role in the identification and treatment of chemotherapy- and radiation therapy-induced diarrhea.
引用
收藏
页码:413 / 417
页数:5
相关论文
共 50 条
  • [1] Antidiarrheal agents for the management of treatment-related diarrhea in cancer patients
    Ippoliti, C
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (15) : 1573 - 1580
  • [2] Evaluation and management of treatment-related diarrhea in patients with advanced cancer: A review
    Cherny, Nathan I.
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2008, 36 (04) : 413 - 423
  • [3] Management of cancer treatment-related diarrhea: Issues and therapeutic strategies
    Kornblau, S
    Benson, AB
    Catalano, R
    Champlin, RE
    Engelking, C
    Field, M
    Ippoliti, C
    Lazarus, HM
    Mitchell, E
    Rubin, J
    Stiff, PJ
    Vokes, E
    Wadler, S
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2000, 19 (02) : 118 - 129
  • [4] PATIENT-CENTRIC APPROACH TO MANAGING CANCER TREATMENT-RELATED DIARRHEA
    Hong, Agnes
    Ahluwalia, Nina
    Ma, Han
    Tarekegn, Selamawit
    Chan, Wai
    Petersen, Jennifer A.
    [J]. ONCOLOGY NURSING FORUM, 2018, 45 (02)
  • [5] Treatment-Related Mortality With Everolimus in Cancer Patients
    Wesolowski, Robert
    Abdel-Rasoul, Mahmoud
    Lustberg, Maryam
    Paskell, Maria
    Shapiro, Charles L.
    Macrae, Erin R.
    [J]. ONCOLOGIST, 2014, 19 (06): : 661 - 668
  • [6] Treatment-related mortality with aflibercept in cancer patients
    Josep Tabernero
    Simon Hitier
    Eric Derobert
    Eric Van Cutsem
    [J]. European Journal of Clinical Pharmacology, 2014, 70 : 1269 - 1270
  • [7] Treatment-related mortality with aflibercept in cancer patients
    Tabernero, Josep
    Hitier, Simon
    Derobert, Eric
    Van Cutsem, Eric
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (10) : 1269 - 1270
  • [8] Treatment-related dysgeusia in head and neck cancer patients
    Irune, Ekpemi
    Dwivedi, Raghav C.
    Nutting, Christopher M.
    Harrington, Kevin J.
    [J]. CANCER TREATMENT REVIEWS, 2014, 40 (09) : 1106 - 1117
  • [9] Cancer Treatment-Related Complications in Patients With Hypertrophic Cardiomyopathy
    Zampieri, Mattia
    Schoonvelde, Stephan A. C.
    Vinci, Michele
    Meattini, Icro
    Visani, Luca
    Fornaro, Alessandra
    Coppini, Raffaele
    Romei, Andrea
    Marchi, Alberto
    Morelli, Ilaria
    van Slegtenhorst, Marion A.
    Palinkas, Eszter Dalma
    Livi, Lorenzo
    Michels, Michelle
    Olivotto, Iacopo
    [J]. MAYO CLINIC PROCEEDINGS, 2024, 99 (02) : 218 - 228
  • [10] Risk of Treatment-related Mortality with Sorafenib in Patients with Cancer
    Zhang, Xin-Ji
    Zhang, Tian-Yi
    Yu, Fei-Fei
    Wei, Xin
    Li, Ye-Sheng
    Xu, Feng
    Wei, Li-Xin
    He, Jia
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (11) : 6681 - 6686